Pamisell has ranked among the top searched stocks for 13 days in the past month.
As of 2:31 PM on the 28th, Pamisell is trading at 17,700 KRW, down 0.84% from the previous day. This represents a 20.98% decrease compared to August 31. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net sellers of 106,699 shares. Over the past five days, individual investors have net sold 151,735 shares, while foreigners and institutions have net bought 117,517 shares and 35,552 shares, respectively.
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
